Stockscreener 앱 받기
0.00
100.00%
-3.37
Acasti Pharma Inc 주식(ACST)의 최신 뉴스
Acasti and CordenPharma look to continuous production for omega-3 drug - OutSourcing-Pharma.com
Acasti Pharma stock soars to 52-week high of $3.61 By Investing.com - Investing.com Canada
Acasti Pharma stock soars to 52-week high of $3.61 - Investing.com
Acasti Pharma (CVE:ACST) Stock Price Up 1.8% – What’s Next? - Defense World
Acasti Pharma to Report Third Quarter 2023 Financial Results on Tuesday, February 14, 2023 - Quantisnow
Financial Contrast: Annexon (NASDAQ:ANNX) & Acasti Pharma (NASDAQ:ACST) - Defense World
Block Inc (SQ-N) QuotePress Release - The Globe and Mail
Acasti Pharma Inc. Announces Poster Detailing Its GTX-104 STRIVE-ON Trial - Marketscreener.com
OTC Markets Hosts Virtual Investor Presentation with Prashant Kohli, CEO of Grace Therapeutics (Acasti Pharma), with John Vandermosten, Senior Analyst at Zacks SCR - MSN
Acasti Pharma Inc. Announces Resignation of Jean-Marie Canan from Board of Directors and Member of Audit Committee and Governance and Human Resources Committee - Marketscreener.com
Acasti Pharma Insider Bought Shares Worth $1,249,934, According to a Recent SEC Filing - Marketscreener.com
Grace Therapeutics announces name change and new ticker - Investing.com India
Reviewing Immunic (NASDAQ:IMUX) & Acasti Pharma (NASDAQ:ACST) - Defense World
Acasti Pharma transitions to Grace Therapeutics, trading as GRCE - Investing.com India
ACSTAcasti Pharma, Inc. Latest Stock News & Market Updates - StockTitan
Acasti Pharma Changes Name to Grace Therapeutics - Marketscreener.com
Acasti Pharma transitions to Grace Therapeutics, trading as GRCE By Investing.com - Investing.com UK
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc. - GlobeNewswire
Acasti Pharma stock soars to 52-week high of $3.6 amid bullish run - Investing.com
Acasti Pharma (FRA:L8S) Debt-to-EBITDA : 0.00 (As of Jun. 2024) - GuruFocus.com
Acasti Pharma (NASDAQ:ACST) Stock Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Aneurysmal Subarachnoid Hemorrhage Market Expected - openPR
Acasti Pharma announces key corporate changes and new incentive plan By Investing.com - Investing.com Canada
Acasti Pharma announces key corporate changes and new incentive plan - Investing.com
Acasti Pharma shares gain analyst confidence, price target raised based on GTX-104 potential - Investing.com Canada
Acasti Pharma shares maintain Buy rating from H.C. Wainwright By Investing.com - Investing.com Canada
Investment Analysts’ Price Target Changes for September 26th (ACST, AFL, ALLY, AVAP, BK, BLKB, CCI, CHRW, CNXC, CROX) - Defense World
Acasti Pharma (ACST) Stock Surges Following Major Clinical Trial Milestone - Stocks Telegraph
Astera Labs director Jack Lazar sells over $1.2m in stock - Investing.com India
Comparing ARS Pharmaceuticals (NASDAQ:SPRY) & Actinium Pharmaceuticals (NYSE:ATNM) - Defense World
Astria Therapeutics (NASDAQ:ATXS) Shares Gap Down to $12.50 - MarketBeat
A year in review: Astria Therapeutics Inc (ATXS)’s performance in the last year - US Post News
Deeper Dive: Understanding Astera Labs Inc. (ALAB) Through its Various Ratios - The Dwinnex
Acadia Pharmaceuticals Inc (ACAD) Stock: A 52-Week Tale of Drops and Gains - The InvestChronicle
Acasti Pharma Inc. Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104 - Marketscreener.com
Acasti Announces Completion of Patient Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial of GTX-104 - GlobeNewswire
Casey’s General Stores, Inc. (NASDAQ:CASY) Shares Sold by Public Employees Retirement Association of Colorado - Defense World
Victory Capital Management Inc. Has $88,000 Position in Acacia Research Co. (NASDAQ:ACTG) - Defense World
Aterian Plc Expands Share Capital and Grants Warrants - TipRanks
Actinium Pharmaceuticals (ATNM) vs. Its Rivals Head to Head Comparison - Defense World
asti stock touches 52-week low at $2.32 amid steep annual decline - Investing.com India
Sagefield Capital LP Invests $1.64 Million in Atlantica Sustainable Infrastructure plc (NASDAQ:AY) - Defense World
1832 Asset Management L.P. Cuts Holdings in Casey’s General Stores, Inc. (NASDAQ:CASY) - Defense World
Acadia Pharmaceuticals appoints Catherine Owen Adams CEO, shares fall - XM
Magnetar Financial LLC Buys Shares of 20,305 Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Views of Wall Street’s Leading Experts on Astera Labs Inc. - SETE News
Acadia Pharmaceuticals Inc (ACAD) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Skandinaviska Enskilda Banken AB publ Acquires 900 Shares of Acuity Brands, Inc. (NYSE:AYI) - Defense World
Astria Therapeutics, Inc. (NASDAQ:ATXS) Shares Sold by Logos Global Management LP - MarketBeat
Long Term Trading Analysis for (ATXS) - Stock Traders Daily
Casey's General Stores, Inc. (NASDAQ:CASY) Position Lifted by Samlyn Capital LLC - MarketBeat
Astera Labs, Inc. (NASDAQ:ALAB) Shares Sold by American Century Companies Inc. - Defense World
Actinogen Medical’s Top Shareholders Unveiled - TipRanks
Shift in Power: Australian Clinical Labs’ Key Shareholders - TipRanks
Acadia Pharmaceuticals appoints new CEO, shares jump 10% - Investing.com
Catherine Owen Adams Succeeds Steve Davis as CEO of Acadia Pharmaceuticals - Business Wire
Will Astera Labs Inc. (ALAB) meet earnings estimates this quarter? - US Post News
Healthy Upside Potential: Astria Therapeutics Inc (ATXS) - SETE News
ProShare Advisors LLC Sells 6,338 Shares of Casey’s General Stores, Inc. (NASDAQ:CASY) - Defense World
Discovery Capital Management LLC CT Reduces Stake in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
Epoch Investment Partners Inc. Sells 18,250 Shares of Casey’s General Stores, Inc. (NASDAQ:CASY) - Defense World
Rhumbline Advisers Takes $1.01 Million Position in Astera Labs, Inc. (NASDAQ:ALAB) - Defense World
2.88%
2.65%
자본화:
|
볼륨(24시간):